Related Experiment Video
Updated: Jun 20, 2026
Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood
Published on: October 12, 2012
Automated assay for fondaparinux (Arixtra) on the Dade Behring BCS XP
Michael J Sanfelippo1, Veronica B Tillema
1Department of Hematology/Coagulation Services, Marshfield Labs, Marshfield Clinic, Marshfield, WI 54449, USA.
Abstract:
An assay for fondaparinux (Arixtra) is described based on a modified commercial assay for heparin. The assay is automated on a Dade Behring BCS XP (Siemens Healthcare Diagnostics, Deerfield, IL) and uses the inhibition of activated factor X to quantitate the drug. The assay was unaffected by platelet contamination or the presence of warfarin. The assay was affected by the antithrombin level, and the value obtained in the assay decreased significantly when the antithrombin level was less than 60%. The assay is, however, not specific for fondaparinux. Specimens containing unfractionated or low-molecular-weight heparin will yield results by this assay that will not be an accurate estimation of concentration.
